Indolent Lymphoma

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Indolent Lymphoma, Low-dose Radiotherapy Trial in Beijing (Low-dose radiotherapy)

Recruiting
  • Indolent Lymphoma
  • Low-dose Radiotherapy
  • Low-dose radiotherapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Sep 13, 2022

CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)

Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
Aug 19, 2022

Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Trial in Australia, United States (NKX019)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +9 more
  • NKX019
  • Denver, Colorado
  • +6 more
Jan 19, 2022

Indolent Lymphoma Trial in Tel Aviv (vegan diet and lifestyle changes)

Recruiting
  • Indolent Lymphoma
  • vegan diet and lifestyle changes
  • Tel Aviv, Israel
    Tel-Aviv Sourasky Medical Center
Jul 5, 2021

Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Tucson (rituximab, bortezomib, cladribine)

Completed
  • Lymphoma
  • +3 more
  • Tucson, Arizona
    The University of Arizona Cancer Center
Dec 16, 2019

Indolent Lymphoma Trial (Ledipasvir and sofosbuvir)

Unknown status
  • Indolent Lymphoma
  • Ledipasvir and sofosbuvir
  • (no location specified)
Aug 23, 2017

Indolent Lymphoma Trial in Ludwigshafen (Therapy with Rituximab, Gemcitabine and Oxaliplatin)

Terminated
  • Indolent Lymphoma
  • Therapy with Rituximab, Gemcitabine and Oxaliplatin
  • Ludwigshafen, Germany
    Klinikum Ludwigshafen
Aug 17, 2015

Hodgkin Lymphoma, Mantle Cell Lymphoma, Indolent Lymphoma Trial in Canada, United States (SB1518)

Completed
  • Hodgkin Lymphoma
  • +2 more
  • Omaha, Nebraska
  • +4 more
Apr 19, 2012

11C-Acetate PET/CT Non-FDG-Avid Tumors

Unknown status
  • Soft Tissue Sarcomas
  • +9 more
    • Tel Aviv, Israel
      Department of Nuclear Medicine, Tel Aviv Sourasky Medical Center
    May 30, 2008